Literature DB >> 22988876

The importance of Wnt signalling for neurodegeneration in Parkinson's disease.

Daniel C Berwick1, Kirsten Harvey.   

Abstract

PD (Parkinson's disease) is a devastating progressive motor disorder with no available cure. Over the last two decades, an increasing number of genetic defects have been found that cause familial and idiopathic forms of PD. In parallel, the importance of Wnt signalling pathways for the healthy functioning of the adult brain and the dysregulation of these pathways in neurodegenerative disease has become apparent. Cell biological functions disrupted in PD are partially controlled by Wnt signalling pathways and proteins encoded by PARK genes have been shown to modify Wnt signalling. This suggests the prospect of targeting Wnt signalling pathways to modify PD progression.

Entities:  

Mesh:

Year:  2012        PMID: 22988876     DOI: 10.1042/BST20120122

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  56 in total

Review 1.  Development of anticancer agents targeting the Wnt/β-catenin signaling.

Authors:  Xiangqian Zhang; Jijun Hao
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

Review 2.  Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis.

Authors:  Anna Tury; Kristine Tolentino; Yimin Zou
Journal:  Dev Neurobiol       Date:  2014-01-22       Impact factor: 3.964

3.  Discovery of a small-molecule inhibitor of Dvl-CXXC5 interaction by computational approaches.

Authors:  Songling Ma; Jiwon Choi; Xuemei Jin; Hyun-Yi Kim; Ji-Hye Yun; Weontae Lee; Kang-Yell Choi; Kyoung Tai No
Journal:  J Comput Aided Mol Des       Date:  2018-04-07       Impact factor: 3.686

4.  Genetic Variants in WNT2B and BTRC Predict Melanoma Survival.

Authors:  Qiong Shi; Hongliang Liu; Peng Han; Chunying Li; Yanru Wang; Wenting Wu; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Jiali Han; Qingyi Wei
Journal:  J Invest Dermatol       Date:  2017-05-10       Impact factor: 8.551

Review 5.  Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics.

Authors:  Jerry Harb; Pen-Jen Lin; Jijun Hao
Journal:  Curr Oncol Rep       Date:  2019-02-04       Impact factor: 5.075

Review 6.  Can we safely target the WNT pathway?

Authors:  Michael Kahn
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

7.  Characterization of secondary structure and lipid binding behavior of N-terminal saposin like subdomain of human Wnt3a.

Authors:  Aparna Krishnamoorthy; Andrzej Witkowski; Jesse J Tran; Paul M M Weers; Robert O Ryan
Journal:  Arch Biochem Biophys       Date:  2017-07-25       Impact factor: 4.013

Review 8.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

9.  Long non-coding RNA Hottip modulates high-glucose-induced inflammation and ECM accumulation through miR-455-3p/WNT2B in mouse mesangial cells.

Authors:  Xiang-Jun Zhu; Zhaung Gong; Shu-Juan Li; Hai-Ping Jia; Da-Lin Li
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

10.  Parkinson's Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning.

Authors:  D M Vargas; M A De Bastiani; R B Parsons; F Klamt
Journal:  Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.